The University of California, San Diego (UCSD) has been awarded a $599,191 Project Grant from the National Cancer Institute's Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop and validate new perfusion measurements that characterize tumor vascular properties using 3D dynamic contrast-enhanced ultrasound (3D DCE-US) imaging. The award, effective September 16, 2024, supports research aimed at capturing complex vascular flow information beyond conventional parameters to enable improved bedside diagnostic and treatment monitoring capabilities for liver malignancies. The project leverages UCSD's expertise in non-invasive 3D DCE-US liver imaging to advance computational approaches that characterize interconnected voxel-level vascular networks, with the goal of identifying new biomarkers representative of the underlying tumor vasculature. The research will extensively validate these novel perfusion measurements and clinically evaluate their utility for diagnostics and treatment response assessment in real patient studies.
Generated 3/4/25, 7:21 AM